NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

OTC Markets · Asset Management · USD

BNB Plus Corp. (BNBX) Stock Analysis

BNB Plus Corp. (BNBX) is a Asset Management stock listed on OTC Markets and quoted in US Dollar.

BNBX

$0.14

−$0.03 (−17.65%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare BNBX with… →

BNBX Key Statistics

As of Sep 4, 2026
Trading
Open
$0.14
Previous Close
$0.17
Day's Range
0.14–0.18
52-Week Range
0.07–7.15
Volume
10.10K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.60
Valuation
Market Cap
$867.61K
P/E Ratio
0.00
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.27
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.36
EPS (ttm)Profit attributable to each share over the last twelve months.
117.37
Financials (FY)
Revenue (FY)
$2.14M+1.11%
Net Income (FY)
−$15.16M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
6.20M
1-Year Return
−95.14%
Dividend and dates
Avg Volume
186.65K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

BNBX Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−88.62%
2025−99.18%
2024−98.39%
2023−62.65%
2022−58.71%
2021−21.18%
2020+21.72%
2019−73.81%
2018−74.84%
2017−14.05%
2016 (partial year)−41.64%

As of September 4, 2026.

BNBX Revenue and Earnings by Fiscal Year

FY ends September
Fiscal yearRevenueNet incomeNet margin
2025$2.14M−$15.16M−709.5%
2024$2.11M−$6.99M−330.9%
2023$13.37M−$9.95M−74.4%
2022$18.17M−$8.27M−45.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$2.14M$838.91K−$16.05M−$15.16M−709.5%
2024$2.11M$974.84K−$13.67M−$6.99M−330.9%
2023$13.37M$5.53M−$10.95M−$9.95M−74.4%
2022$18.17M$5.05M−$13.97M−$8.27M−45.5%

Annual figures as reported, in the company's reporting currency. As of September 30, 2025.

BNBX Valuation vs Asset Management Median

Median of 561 stocks
MetricBNBXAsset Management medianvs median
P/E0.0010.340.0x the median
P/S ratio0.3610.420.0x the median
Profit margin0.00%24.09%24.1 pts below

Medians across 561 Asset Management stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

BNB Plus Corp. (BNBX) is capitalised at $867.61K on the latest close. The company sits in the Financial Services sector, in the Asset Management industry. The company reports 26 employees.

The 52-week range on file runs from $0.07 to $7.15. The most recent close on file for BNBX is $0.14, dated September 4, 2026. That is −$0.03 (−17.65%) against the previous close. The latest close sits 100% above that 52-week low.

Financial Health

In fiscal 2025, BNB Plus Corp. reported revenue of $2.14M. Against the prior fiscal year total of $2.11M, that is a change of +1.11%. The same year closed with a net loss of $15.16M. Profit margin runs at 0%. That is 24.1 percentage points below the Asset Management median of 24.09%. Trailing earnings per share are 117.37.

Across the 4 fiscal years on file, revenue moves from $18.17M in 2022 to $2.14M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 0 times earnings. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.27. Measured against sales, the shares trade at 0.36 times revenue. On price-to-sales that is 0 times the Asset Management median of 10.42. 561 Asset Management companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 0.61. Annualized volatility over the trailing 10 years is 203.19%. Over the trailing twelve months the price has returned −95.14%. Across 10 years the annualized return works out at −80.67%.

Growth & Income

No dividend is on file for BNBX.

The strongest complete calendar year on file is 2020 at +21.72%; the weakest is 2025 at −99.18%. Of the 9 complete calendar years on file, 1 finished higher. 2026 is still running; the price is −88.62% year to date.

Peer Comparison

BNB Plus Corp. (BNBX) operates in the Asset Management industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
BNB Plus Corp. BNBX $867.61K 0.0
BlackRock, Inc. BLK $182.35B 26.9
Blackstone Inc. BX $162.74B 30.5
KKR & Co. Inc. KKR $99.50B 34.4

The Asset Management industry average P/E ratio is 10.3x. BNB Plus Corp. trades at a P/E of 0.0.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Asset Management Stocks

BLK

BlackRock, Inc.

$182.35B

 BX

Blackstone Inc.

$162.74B

 KKR

KKR & Co. Inc.

$99.50B

 BN

Brookfield Corporation

$89.99B

 BAM

Brookfield Asset Management Ltd.

$80.82B

 APO

Apollo Global Management, Inc.

$78.94B
View all Asset Management stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.08T

 JPM

JPMorgan Chase & Co.

$953.33B

 V

Visa Inc.

$700.27B

 MA

Mastercard Incorporated

$507.39B

 BAC

Bank of America Corporation

$438.31B
View all Financial Services stocks →

About BNB Plus Corp.

BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP, and LineaIVT, as well as the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. BNB Plus Corp. was formerly known as Applied DNA Sciences, Inc. and changed its name to BNB Plus Corp. in November 2025. The company was founded in 1983 and is based in Stony Brook, New York.

Visit website →